Medical Care
Global Pediatric Psoriasis Market Research Report 2025
- May 12, 25
- ID: 236274
- Pages: 77
- Figures: 71
- Views: 3
The global market for Pediatric Psoriasis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Pediatric Psoriasis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pediatric Psoriasis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pediatric Psoriasis in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pediatric Psoriasis include Abbvie Inc, Amgen Inc, Johnson & Johnson, Novartis Ag, Eli Lilly & Company, Astrazeneca, Celgene Corporation, Merck, Boehringer Ingelheim, Leo Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pediatric Psoriasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Psoriasis.
The Pediatric Psoriasis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Psoriasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Psoriasis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie Inc
Amgen Inc
Johnson & Johnson
Novartis Ag
Eli Lilly & Company
Astrazeneca
Celgene Corporation
Merck
Boehringer Ingelheim
Leo Pharma
Segment by Type
Oral
Injection
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Psoriasis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Pediatric Psoriasis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pediatric Psoriasis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pediatric Psoriasis in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pediatric Psoriasis include Abbvie Inc, Amgen Inc, Johnson & Johnson, Novartis Ag, Eli Lilly & Company, Astrazeneca, Celgene Corporation, Merck, Boehringer Ingelheim, Leo Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pediatric Psoriasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Psoriasis.
The Pediatric Psoriasis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Psoriasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Psoriasis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie Inc
Amgen Inc
Johnson & Johnson
Novartis Ag
Eli Lilly & Company
Astrazeneca
Celgene Corporation
Merck
Boehringer Ingelheim
Leo Pharma
Segment by Type
Oral
Injection
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Psoriasis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Psoriasis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pediatric Psoriasis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Psoriasis Market Perspective (2020-2031)
2.2 Global Pediatric Psoriasis Growth Trends by Region
2.2.1 Global Pediatric Psoriasis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pediatric Psoriasis Historic Market Size by Region (2020-2025)
2.2.3 Pediatric Psoriasis Forecasted Market Size by Region (2026-2031)
2.3 Pediatric Psoriasis Market Dynamics
2.3.1 Pediatric Psoriasis Industry Trends
2.3.2 Pediatric Psoriasis Market Drivers
2.3.3 Pediatric Psoriasis Market Challenges
2.3.4 Pediatric Psoriasis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Psoriasis Players by Revenue
3.1.1 Global Top Pediatric Psoriasis Players by Revenue (2020-2025)
3.1.2 Global Pediatric Psoriasis Revenue Market Share by Players (2020-2025)
3.2 Global Pediatric Psoriasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Psoriasis Revenue
3.4 Global Pediatric Psoriasis Market Concentration Ratio
3.4.1 Global Pediatric Psoriasis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Psoriasis Revenue in 2024
3.5 Global Key Players of Pediatric Psoriasis Head office and Area Served
3.6 Global Key Players of Pediatric Psoriasis, Product and Application
3.7 Global Key Players of Pediatric Psoriasis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Psoriasis Breakdown Data by Type
4.1 Global Pediatric Psoriasis Historic Market Size by Type (2020-2025)
4.2 Global Pediatric Psoriasis Forecasted Market Size by Type (2026-2031)
5 Pediatric Psoriasis Breakdown Data by Application
5.1 Global Pediatric Psoriasis Historic Market Size by Application (2020-2025)
5.2 Global Pediatric Psoriasis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pediatric Psoriasis Market Size (2020-2031)
6.2 North America Pediatric Psoriasis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pediatric Psoriasis Market Size by Country (2020-2025)
6.4 North America Pediatric Psoriasis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Psoriasis Market Size (2020-2031)
7.2 Europe Pediatric Psoriasis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pediatric Psoriasis Market Size by Country (2020-2025)
7.4 Europe Pediatric Psoriasis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Psoriasis Market Size (2020-2031)
8.2 Asia-Pacific Pediatric Psoriasis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pediatric Psoriasis Market Size by Region (2020-2025)
8.4 Asia-Pacific Pediatric Psoriasis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Psoriasis Market Size (2020-2031)
9.2 Latin America Pediatric Psoriasis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pediatric Psoriasis Market Size by Country (2020-2025)
9.4 Latin America Pediatric Psoriasis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Psoriasis Market Size (2020-2031)
10.2 Middle East & Africa Pediatric Psoriasis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pediatric Psoriasis Market Size by Country (2020-2025)
10.4 Middle East & Africa Pediatric Psoriasis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie Inc
11.1.1 Abbvie Inc Company Details
11.1.2 Abbvie Inc Business Overview
11.1.3 Abbvie Inc Pediatric Psoriasis Introduction
11.1.4 Abbvie Inc Revenue in Pediatric Psoriasis Business (2020-2025)
11.1.5 Abbvie Inc Recent Development
11.2 Amgen Inc
11.2.1 Amgen Inc Company Details
11.2.2 Amgen Inc Business Overview
11.2.3 Amgen Inc Pediatric Psoriasis Introduction
11.2.4 Amgen Inc Revenue in Pediatric Psoriasis Business (2020-2025)
11.2.5 Amgen Inc Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Pediatric Psoriasis Introduction
11.3.4 Johnson & Johnson Revenue in Pediatric Psoriasis Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis Ag
11.4.1 Novartis Ag Company Details
11.4.2 Novartis Ag Business Overview
11.4.3 Novartis Ag Pediatric Psoriasis Introduction
11.4.4 Novartis Ag Revenue in Pediatric Psoriasis Business (2020-2025)
11.4.5 Novartis Ag Recent Development
11.5 Eli Lilly & Company
11.5.1 Eli Lilly & Company Company Details
11.5.2 Eli Lilly & Company Business Overview
11.5.3 Eli Lilly & Company Pediatric Psoriasis Introduction
11.5.4 Eli Lilly & Company Revenue in Pediatric Psoriasis Business (2020-2025)
11.5.5 Eli Lilly & Company Recent Development
11.6 Astrazeneca
11.6.1 Astrazeneca Company Details
11.6.2 Astrazeneca Business Overview
11.6.3 Astrazeneca Pediatric Psoriasis Introduction
11.6.4 Astrazeneca Revenue in Pediatric Psoriasis Business (2020-2025)
11.6.5 Astrazeneca Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Details
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Pediatric Psoriasis Introduction
11.7.4 Celgene Corporation Revenue in Pediatric Psoriasis Business (2020-2025)
11.7.5 Celgene Corporation Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Pediatric Psoriasis Introduction
11.8.4 Merck Revenue in Pediatric Psoriasis Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Pediatric Psoriasis Introduction
11.9.4 Boehringer Ingelheim Revenue in Pediatric Psoriasis Business (2020-2025)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Leo Pharma
11.10.1 Leo Pharma Company Details
11.10.2 Leo Pharma Business Overview
11.10.3 Leo Pharma Pediatric Psoriasis Introduction
11.10.4 Leo Pharma Revenue in Pediatric Psoriasis Business (2020-2025)
11.10.5 Leo Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Psoriasis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pediatric Psoriasis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Psoriasis Market Perspective (2020-2031)
2.2 Global Pediatric Psoriasis Growth Trends by Region
2.2.1 Global Pediatric Psoriasis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pediatric Psoriasis Historic Market Size by Region (2020-2025)
2.2.3 Pediatric Psoriasis Forecasted Market Size by Region (2026-2031)
2.3 Pediatric Psoriasis Market Dynamics
2.3.1 Pediatric Psoriasis Industry Trends
2.3.2 Pediatric Psoriasis Market Drivers
2.3.3 Pediatric Psoriasis Market Challenges
2.3.4 Pediatric Psoriasis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Psoriasis Players by Revenue
3.1.1 Global Top Pediatric Psoriasis Players by Revenue (2020-2025)
3.1.2 Global Pediatric Psoriasis Revenue Market Share by Players (2020-2025)
3.2 Global Pediatric Psoriasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Psoriasis Revenue
3.4 Global Pediatric Psoriasis Market Concentration Ratio
3.4.1 Global Pediatric Psoriasis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Psoriasis Revenue in 2024
3.5 Global Key Players of Pediatric Psoriasis Head office and Area Served
3.6 Global Key Players of Pediatric Psoriasis, Product and Application
3.7 Global Key Players of Pediatric Psoriasis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Psoriasis Breakdown Data by Type
4.1 Global Pediatric Psoriasis Historic Market Size by Type (2020-2025)
4.2 Global Pediatric Psoriasis Forecasted Market Size by Type (2026-2031)
5 Pediatric Psoriasis Breakdown Data by Application
5.1 Global Pediatric Psoriasis Historic Market Size by Application (2020-2025)
5.2 Global Pediatric Psoriasis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pediatric Psoriasis Market Size (2020-2031)
6.2 North America Pediatric Psoriasis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pediatric Psoriasis Market Size by Country (2020-2025)
6.4 North America Pediatric Psoriasis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Psoriasis Market Size (2020-2031)
7.2 Europe Pediatric Psoriasis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pediatric Psoriasis Market Size by Country (2020-2025)
7.4 Europe Pediatric Psoriasis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Psoriasis Market Size (2020-2031)
8.2 Asia-Pacific Pediatric Psoriasis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pediatric Psoriasis Market Size by Region (2020-2025)
8.4 Asia-Pacific Pediatric Psoriasis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Psoriasis Market Size (2020-2031)
9.2 Latin America Pediatric Psoriasis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pediatric Psoriasis Market Size by Country (2020-2025)
9.4 Latin America Pediatric Psoriasis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Psoriasis Market Size (2020-2031)
10.2 Middle East & Africa Pediatric Psoriasis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pediatric Psoriasis Market Size by Country (2020-2025)
10.4 Middle East & Africa Pediatric Psoriasis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie Inc
11.1.1 Abbvie Inc Company Details
11.1.2 Abbvie Inc Business Overview
11.1.3 Abbvie Inc Pediatric Psoriasis Introduction
11.1.4 Abbvie Inc Revenue in Pediatric Psoriasis Business (2020-2025)
11.1.5 Abbvie Inc Recent Development
11.2 Amgen Inc
11.2.1 Amgen Inc Company Details
11.2.2 Amgen Inc Business Overview
11.2.3 Amgen Inc Pediatric Psoriasis Introduction
11.2.4 Amgen Inc Revenue in Pediatric Psoriasis Business (2020-2025)
11.2.5 Amgen Inc Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Pediatric Psoriasis Introduction
11.3.4 Johnson & Johnson Revenue in Pediatric Psoriasis Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis Ag
11.4.1 Novartis Ag Company Details
11.4.2 Novartis Ag Business Overview
11.4.3 Novartis Ag Pediatric Psoriasis Introduction
11.4.4 Novartis Ag Revenue in Pediatric Psoriasis Business (2020-2025)
11.4.5 Novartis Ag Recent Development
11.5 Eli Lilly & Company
11.5.1 Eli Lilly & Company Company Details
11.5.2 Eli Lilly & Company Business Overview
11.5.3 Eli Lilly & Company Pediatric Psoriasis Introduction
11.5.4 Eli Lilly & Company Revenue in Pediatric Psoriasis Business (2020-2025)
11.5.5 Eli Lilly & Company Recent Development
11.6 Astrazeneca
11.6.1 Astrazeneca Company Details
11.6.2 Astrazeneca Business Overview
11.6.3 Astrazeneca Pediatric Psoriasis Introduction
11.6.4 Astrazeneca Revenue in Pediatric Psoriasis Business (2020-2025)
11.6.5 Astrazeneca Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Details
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Pediatric Psoriasis Introduction
11.7.4 Celgene Corporation Revenue in Pediatric Psoriasis Business (2020-2025)
11.7.5 Celgene Corporation Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Pediatric Psoriasis Introduction
11.8.4 Merck Revenue in Pediatric Psoriasis Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Pediatric Psoriasis Introduction
11.9.4 Boehringer Ingelheim Revenue in Pediatric Psoriasis Business (2020-2025)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Leo Pharma
11.10.1 Leo Pharma Company Details
11.10.2 Leo Pharma Business Overview
11.10.3 Leo Pharma Pediatric Psoriasis Introduction
11.10.4 Leo Pharma Revenue in Pediatric Psoriasis Business (2020-2025)
11.10.5 Leo Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pediatric Psoriasis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of Others
Table 5. Global Pediatric Psoriasis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Pediatric Psoriasis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pediatric Psoriasis Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Pediatric Psoriasis Market Share by Region (2020-2025)
Table 9. Global Pediatric Psoriasis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Pediatric Psoriasis Market Share by Region (2026-2031)
Table 11. Pediatric Psoriasis Market Trends
Table 12. Pediatric Psoriasis Market Drivers
Table 13. Pediatric Psoriasis Market Challenges
Table 14. Pediatric Psoriasis Market Restraints
Table 15. Global Pediatric Psoriasis Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Pediatric Psoriasis Market Share by Players (2020-2025)
Table 17. Global Top Pediatric Psoriasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Psoriasis as of 2024)
Table 18. Ranking of Global Top Pediatric Psoriasis Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Pediatric Psoriasis Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Pediatric Psoriasis, Headquarters and Area Served
Table 21. Global Key Players of Pediatric Psoriasis, Product and Application
Table 22. Global Key Players of Pediatric Psoriasis, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediatric Psoriasis Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Pediatric Psoriasis Revenue Market Share by Type (2020-2025)
Table 26. Global Pediatric Psoriasis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Pediatric Psoriasis Revenue Market Share by Type (2026-2031)
Table 28. Global Pediatric Psoriasis Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Pediatric Psoriasis Revenue Market Share by Application (2020-2025)
Table 30. Global Pediatric Psoriasis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Pediatric Psoriasis Revenue Market Share by Application (2026-2031)
Table 32. North America Pediatric Psoriasis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Pediatric Psoriasis Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Pediatric Psoriasis Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Pediatric Psoriasis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Pediatric Psoriasis Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Pediatric Psoriasis Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Pediatric Psoriasis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Pediatric Psoriasis Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Pediatric Psoriasis Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Pediatric Psoriasis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Pediatric Psoriasis Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Pediatric Psoriasis Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Pediatric Psoriasis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Pediatric Psoriasis Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Pediatric Psoriasis Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abbvie Inc Company Details
Table 48. Abbvie Inc Business Overview
Table 49. Abbvie Inc Pediatric Psoriasis Product
Table 50. Abbvie Inc Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 51. Abbvie Inc Recent Development
Table 52. Amgen Inc Company Details
Table 53. Amgen Inc Business Overview
Table 54. Amgen Inc Pediatric Psoriasis Product
Table 55. Amgen Inc Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 56. Amgen Inc Recent Development
Table 57. Johnson & Johnson Company Details
Table 58. Johnson & Johnson Business Overview
Table 59. Johnson & Johnson Pediatric Psoriasis Product
Table 60. Johnson & Johnson Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 61. Johnson & Johnson Recent Development
Table 62. Novartis Ag Company Details
Table 63. Novartis Ag Business Overview
Table 64. Novartis Ag Pediatric Psoriasis Product
Table 65. Novartis Ag Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 66. Novartis Ag Recent Development
Table 67. Eli Lilly & Company Company Details
Table 68. Eli Lilly & Company Business Overview
Table 69. Eli Lilly & Company Pediatric Psoriasis Product
Table 70. Eli Lilly & Company Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 71. Eli Lilly & Company Recent Development
Table 72. Astrazeneca Company Details
Table 73. Astrazeneca Business Overview
Table 74. Astrazeneca Pediatric Psoriasis Product
Table 75. Astrazeneca Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 76. Astrazeneca Recent Development
Table 77. Celgene Corporation Company Details
Table 78. Celgene Corporation Business Overview
Table 79. Celgene Corporation Pediatric Psoriasis Product
Table 80. Celgene Corporation Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 81. Celgene Corporation Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Pediatric Psoriasis Product
Table 85. Merck Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Boehringer Ingelheim Company Details
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Pediatric Psoriasis Product
Table 90. Boehringer Ingelheim Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 91. Boehringer Ingelheim Recent Development
Table 92. Leo Pharma Company Details
Table 93. Leo Pharma Business Overview
Table 94. Leo Pharma Pediatric Psoriasis Product
Table 95. Leo Pharma Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 96. Leo Pharma Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Pediatric Psoriasis Picture
Figure 2. Global Pediatric Psoriasis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pediatric Psoriasis Market Share by Type: 2024 VS 2031
Figure 4. Oral Features
Figure 5. Injection Features
Figure 6. Others Features
Figure 7. Global Pediatric Psoriasis Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Pediatric Psoriasis Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Pediatric Psoriasis Report Years Considered
Figure 13. Global Pediatric Psoriasis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Pediatric Psoriasis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Pediatric Psoriasis Market Share by Region: 2024 VS 2031
Figure 16. Global Pediatric Psoriasis Market Share by Players in 2024
Figure 17. Global Top Pediatric Psoriasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Psoriasis as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Pediatric Psoriasis Revenue in 2024
Figure 19. North America Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Pediatric Psoriasis Market Share by Country (2020-2031)
Figure 21. United States Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Pediatric Psoriasis Market Share by Country (2020-2031)
Figure 25. Germany Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Pediatric Psoriasis Market Share by Region (2020-2031)
Figure 33. China Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Pediatric Psoriasis Market Share by Country (2020-2031)
Figure 41. Mexico Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Pediatric Psoriasis Market Share by Country (2020-2031)
Figure 45. Turkey Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Abbvie Inc Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 49. Amgen Inc Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 51. Novartis Ag Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 52. Eli Lilly & Company Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 53. Astrazeneca Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 54. Celgene Corporation Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 56. Boehringer Ingelheim Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 57. Leo Pharma Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Pediatric Psoriasis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of Others
Table 5. Global Pediatric Psoriasis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Pediatric Psoriasis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pediatric Psoriasis Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Pediatric Psoriasis Market Share by Region (2020-2025)
Table 9. Global Pediatric Psoriasis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Pediatric Psoriasis Market Share by Region (2026-2031)
Table 11. Pediatric Psoriasis Market Trends
Table 12. Pediatric Psoriasis Market Drivers
Table 13. Pediatric Psoriasis Market Challenges
Table 14. Pediatric Psoriasis Market Restraints
Table 15. Global Pediatric Psoriasis Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Pediatric Psoriasis Market Share by Players (2020-2025)
Table 17. Global Top Pediatric Psoriasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Psoriasis as of 2024)
Table 18. Ranking of Global Top Pediatric Psoriasis Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Pediatric Psoriasis Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Pediatric Psoriasis, Headquarters and Area Served
Table 21. Global Key Players of Pediatric Psoriasis, Product and Application
Table 22. Global Key Players of Pediatric Psoriasis, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediatric Psoriasis Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Pediatric Psoriasis Revenue Market Share by Type (2020-2025)
Table 26. Global Pediatric Psoriasis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Pediatric Psoriasis Revenue Market Share by Type (2026-2031)
Table 28. Global Pediatric Psoriasis Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Pediatric Psoriasis Revenue Market Share by Application (2020-2025)
Table 30. Global Pediatric Psoriasis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Pediatric Psoriasis Revenue Market Share by Application (2026-2031)
Table 32. North America Pediatric Psoriasis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Pediatric Psoriasis Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Pediatric Psoriasis Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Pediatric Psoriasis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Pediatric Psoriasis Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Pediatric Psoriasis Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Pediatric Psoriasis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Pediatric Psoriasis Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Pediatric Psoriasis Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Pediatric Psoriasis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Pediatric Psoriasis Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Pediatric Psoriasis Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Pediatric Psoriasis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Pediatric Psoriasis Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Pediatric Psoriasis Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abbvie Inc Company Details
Table 48. Abbvie Inc Business Overview
Table 49. Abbvie Inc Pediatric Psoriasis Product
Table 50. Abbvie Inc Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 51. Abbvie Inc Recent Development
Table 52. Amgen Inc Company Details
Table 53. Amgen Inc Business Overview
Table 54. Amgen Inc Pediatric Psoriasis Product
Table 55. Amgen Inc Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 56. Amgen Inc Recent Development
Table 57. Johnson & Johnson Company Details
Table 58. Johnson & Johnson Business Overview
Table 59. Johnson & Johnson Pediatric Psoriasis Product
Table 60. Johnson & Johnson Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 61. Johnson & Johnson Recent Development
Table 62. Novartis Ag Company Details
Table 63. Novartis Ag Business Overview
Table 64. Novartis Ag Pediatric Psoriasis Product
Table 65. Novartis Ag Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 66. Novartis Ag Recent Development
Table 67. Eli Lilly & Company Company Details
Table 68. Eli Lilly & Company Business Overview
Table 69. Eli Lilly & Company Pediatric Psoriasis Product
Table 70. Eli Lilly & Company Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 71. Eli Lilly & Company Recent Development
Table 72. Astrazeneca Company Details
Table 73. Astrazeneca Business Overview
Table 74. Astrazeneca Pediatric Psoriasis Product
Table 75. Astrazeneca Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 76. Astrazeneca Recent Development
Table 77. Celgene Corporation Company Details
Table 78. Celgene Corporation Business Overview
Table 79. Celgene Corporation Pediatric Psoriasis Product
Table 80. Celgene Corporation Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 81. Celgene Corporation Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Pediatric Psoriasis Product
Table 85. Merck Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Boehringer Ingelheim Company Details
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Pediatric Psoriasis Product
Table 90. Boehringer Ingelheim Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 91. Boehringer Ingelheim Recent Development
Table 92. Leo Pharma Company Details
Table 93. Leo Pharma Business Overview
Table 94. Leo Pharma Pediatric Psoriasis Product
Table 95. Leo Pharma Revenue in Pediatric Psoriasis Business (2020-2025) & (US$ Million)
Table 96. Leo Pharma Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Pediatric Psoriasis Picture
Figure 2. Global Pediatric Psoriasis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pediatric Psoriasis Market Share by Type: 2024 VS 2031
Figure 4. Oral Features
Figure 5. Injection Features
Figure 6. Others Features
Figure 7. Global Pediatric Psoriasis Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Pediatric Psoriasis Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Pediatric Psoriasis Report Years Considered
Figure 13. Global Pediatric Psoriasis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Pediatric Psoriasis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Pediatric Psoriasis Market Share by Region: 2024 VS 2031
Figure 16. Global Pediatric Psoriasis Market Share by Players in 2024
Figure 17. Global Top Pediatric Psoriasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Psoriasis as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Pediatric Psoriasis Revenue in 2024
Figure 19. North America Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Pediatric Psoriasis Market Share by Country (2020-2031)
Figure 21. United States Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Pediatric Psoriasis Market Share by Country (2020-2031)
Figure 25. Germany Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Pediatric Psoriasis Market Share by Region (2020-2031)
Figure 33. China Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Pediatric Psoriasis Market Share by Country (2020-2031)
Figure 41. Mexico Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Pediatric Psoriasis Market Share by Country (2020-2031)
Figure 45. Turkey Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Pediatric Psoriasis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Abbvie Inc Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 49. Amgen Inc Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 51. Novartis Ag Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 52. Eli Lilly & Company Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 53. Astrazeneca Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 54. Celgene Corporation Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 56. Boehringer Ingelheim Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 57. Leo Pharma Revenue Growth Rate in Pediatric Psoriasis Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232